Triplet Chemotherapy (FOLFOXIRI) Plus Bevacizumab Versus Doublet Chemotherapy (FOLFOX/FOLFIRI) Plus Bevacizumab in Conversion Therapy for Metastatic Colorectal Cancer: a Meta-Analysis
Lin Shui(West China Medical Center of Sichuan University), Pixian Shui(Southwest Medical University), Yushen Wu, Huapeng Lin(Zhejiang University), Qin Sun(Sichuan University)
Cited by 27
Related Papers
Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease
|JAMA|2024|200
Prognostic value of systemic immune-inflammation index in patients with urologic cancers: a meta-analysis
|Cancer Cell International|2020|125
FGFR blockade boosts T cell infiltration into triple-negative breast cancer by regulating cancer-associated fibroblasts
|Theranostics|2022|118